Allegion plc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $4.3B+13.7% YoYTTM through 30 Jun 2026
Net Income $658.6M+10.2% YoYTTM through 30 Jun 2026
Free Cash Flow $677.2MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 45.2% |
| EBITDA Margin | 23.9% |
| Operating Margin | 21.1% |
| Net Margin | 15.4% |
Returns
31.1%ROE
12.3%ROA
17.4%ROIC
Balance Sheet Health
Debt / Equity0.96x
Current Ratio1.93x
Net Debt$1.6B
Cash & Equivalents$356.2M
Quality Metrics
Altman Z-Score4.55
Piotroski F-Score8 / 9
FCF Margin15.8%
Rule of 4018.7
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $4.1B
Diluted EPS$7.62TTMFY2025: $7.44
Dividend
$1.10Per share, FY20260.71%Yield1 yrsStreak-5.2%5-yr growth
Capital Allocation
R&D Spend$132M
Capex Intensity2.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Allegion Americas | $3.2B | +6.9% | |
| Allegion International | $848.5M | +11.7% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.